|
|
|
Insider
Information: |
Goldfischer Carl |
Relationship: |
Director |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
49,065 |
|
Indirect Shares
|
2,043,293 |
|
|
Direct
Value |
$4 |
|
|
Indirect Value
|
$28 |
|
|
Total
Shares |
2,092,358 |
|
|
Total
Value |
$32 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-44.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Poniard Pharmaceuticals |
PARD |
Director |
2011-06-09 |
39,478 |
2011-06-09 |
279,484 |
Premium* |
|
Map Pharmaceuticals Inc |
MAPP |
Director |
2007-10-11 |
0 |
2010-03-16 |
1,744,377 |
Premium* |
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2022-08-12 |
0 |
Premium* |
|
Cymabay Therapeutics, Inc. |
CBAY |
Director |
2019-02-07 |
0 |
2015-09-11 |
0 |
Premium* |
|
Galecto Inc. |
GLTO |
Director |
2020-11-02 |
9,587 |
2020-11-02 |
19,432 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PARD |
Poniard Pharmaceuticals |
Director |
|
2004-06-28 |
4 |
B |
$2.57 |
$51,300 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2006-04-26 |
4 |
OE |
$0.70 |
$49,898 |
I/I |
71,283 |
71,283 |
|
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2006-04-26 |
4 |
B |
$0.70 |
$871,455 |
I/I |
1,244,935 |
1,316,218 |
2.1 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2007-04-30 |
4 |
B |
$6.33 |
$349,587 |
I/I |
55,227 |
4,653 |
2.1 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2007-08-10 |
4 |
B |
$5.50 |
$3,713 |
I/I |
675 |
4,664 |
2.1 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2007-08-14 |
4 |
B |
$5.50 |
$160 |
I/I |
29 |
4,665 |
2.02 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2007-08-16 |
4 |
B |
$5.48 |
$1,245 |
I/I |
227 |
4,669 |
2.02 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2007-08-29 |
4 |
B |
$5.75 |
$1,402 |
I/I |
244 |
4,672 |
2.02 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2007-08-30 |
4 |
B |
$5.74 |
$21,896 |
I/I |
3,712 |
4,735 |
2.1 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2007-10-11 |
4 |
A |
$14.50 |
$2,559,168 |
I/I |
176,470 |
176,470 |
0 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2007-10-11 |
4 |
OE |
$14.50 |
$31,478,143 |
I/I |
2,170,607 |
2,347,077 |
0 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2010-03-09 |
4 |
S |
$15.50 |
$2,347,072 |
I/I |
(151,424) |
2,195,653 |
0 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2010-03-10 |
4 |
S |
$16.03 |
$2,151,066 |
I/I |
(134,190) |
2,061,463 |
0 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2010-03-11 |
4 |
S |
$16.06 |
$872,058 |
I/I |
(54,300) |
2,007,163 |
0 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2010-03-12 |
4 |
S |
$16.30 |
$1,711,500 |
I/I |
(105,000) |
1,902,163 |
0 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2010-03-15 |
4 |
S |
$16.01 |
$675,238 |
I/I |
(42,176) |
1,859,987 |
0 |
- |
|
MAPP |
Map Pharmaceuticals Inc |
Director |
|
2010-03-16 |
4 |
S |
$16.20 |
$1,872,882 |
I/I |
(115,610) |
1,744,377 |
0 |
- |
|
PARD |
Poniard Pharmaceuticals |
Director |
|
2011-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,145 |
39,478 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2013-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
3,492,063 |
3,492,063 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2013-06-05 |
4 |
B |
$15.00 |
$2,499,990 |
I/I |
166,666 |
3,658,729 |
2.25 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
46,729 |
|
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2014-02-10 |
4 |
S |
$29.25 |
$13,650,010 |
I/I |
(466,667) |
3,192,062 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2014-08-21 |
4 |
S |
$33.04 |
$1,277,339 |
I/I |
(38,666) |
3,153,396 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2014-08-22 |
4 |
S |
$32.46 |
$4,154,765 |
I/I |
(128,000) |
3,025,396 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2014-08-25 |
4 |
S |
$35.13 |
$7,027,803 |
I/I |
(200,000) |
2,825,396 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|